BMJ Open,
Год журнала:
2020,
Номер
10(8), С. e036663 - e036663
Опубликована: Авг. 1, 2020
Objective
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
the
leading
cause
of
end-stage
diseases
worldwide.
Understanding
NAFLD
prevalence
and
trends
over
time
at
global,
regional
national
levels
critical
to
understanding
burden
creating
more
tailored
prevention
strategies.
Design
Population-based
observational
study.
Setting
The
study
was
including
21
regions
195
countries
or
territories.
Main
outcomes
measure
estimated
annual
percentage
change
for
prevalence.
Results
Worldwide,
cases
have
increased
from
391.2
million
in
1990
882.1
2017,
with
rate
increasing
8.2%
10.9%
during
same
period.
were
consistent
across
sexes.
Case
numbers
highest
East
Asia,
followed
by
South
then
North
Africa
Middle
East.
observed
East,
while
greatest
increase
detected
Western
Europe,
Tropical
Latin
America,
high-income
America.
Conclusion
Nearly
all
territories
worldwide
experienced
a
significant
Oman.
Almost
showed
trend
past
three
decades.
This
drastic
alarming
suggests
that
has
emerged
as
new
public
health
concern
As
such,
efficient
strategies
are
urgently
needed.
Journal of Hepatology,
Год журнала:
2021,
Номер
76(4), С. 771 - 780
Опубликована: Дек. 9, 2021
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
highly
prevalent,
yet
largely
underappreciated
condition
which
closely
associated
with
obesity
and
metabolic
disease.
Despite
affecting
an
estimated
1
in
4
adults
globally,
NAFLD
absent
on
national
global
health
agendas.We
collected
data
from
102
countries,
accounting
for
86%
of
the
world
population,
policies,
guidelines,
civil
society
engagement,
clinical
management,
epidemiologic
data.
A
preparedness
index
was
developed
by
coding
questions
into
6
domains
(policies,
awareness,
epidemiology
data,
detection,
care
management)
categorising
responses
as
high,
medium,
low;
multiple
correspondence
analysis
then
applied.The
highest
scoring
countries
were
India
(42.7)
United
Kingdom
(40.0),
32
(31%)
zero
out
100.
For
5
minority
categorised
high-level
while
majority
low-level.
No
country
had
or
sub-national
strategy
<2%
different
strategies
related
conditions
included
any
mention
NAFLD.
National
guidelines
present
only
countries.Although
pressing
public
problem,
no
found
to
be
well
prepared
address
it.
There
need
at
levels.Around
third
scored
policy
index,
over
50/100.
Although
comprehensive
response
lacking
all
countries.
Policies
levels
are
urgently
needed.
BMJ Open,
Год журнала:
2020,
Номер
10(8), С. e036663 - e036663
Опубликована: Авг. 1, 2020
Objective
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
the
leading
cause
of
end-stage
diseases
worldwide.
Understanding
NAFLD
prevalence
and
trends
over
time
at
global,
regional
national
levels
critical
to
understanding
burden
creating
more
tailored
prevention
strategies.
Design
Population-based
observational
study.
Setting
The
study
was
including
21
regions
195
countries
or
territories.
Main
outcomes
measure
estimated
annual
percentage
change
for
prevalence.
Results
Worldwide,
cases
have
increased
from
391.2
million
in
1990
882.1
2017,
with
rate
increasing
8.2%
10.9%
during
same
period.
were
consistent
across
sexes.
Case
numbers
highest
East
Asia,
followed
by
South
then
North
Africa
Middle
East.
observed
East,
while
greatest
increase
detected
Western
Europe,
Tropical
Latin
America,
high-income
America.
Conclusion
Nearly
all
territories
worldwide
experienced
a
significant
Oman.
Almost
showed
trend
past
three
decades.
This
drastic
alarming
suggests
that
has
emerged
as
new
public
health
concern
As
such,
efficient
strategies
are
urgently
needed.
